Companies / Decoy Therapeutics Inc. (f/k/a Salarius Pharmaceuticals, Inc.)

Decoy Therapeutics Inc. (f/k/a Salarius Pharmaceuticals, Inc.)

Nasdaq: SLRXCIK 1615219HOUSTON, TX

Financials · FY2022

Revenue$0
Net income$-12.52M
Total debt—
Cash$8.29M
Diluted EPS$-129.10
Shares outstanding655K

Ownership

655K shares outstanding · as of Aug 12, 2026
0.76%Insiders
Ownership
Insiders0.76%5,000
Public float99.24%650,185

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Hanish Arnold CDirector
0.76%5,000

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 30, 2025Hanish Arnold C
Director
SellCommon Stock$10-15
-0.30%
5,000
0.76% of shares
low
Dec 30, 2025Hanish Arnold C
Director
SellCommon Stock$8-12
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
CVI Investments, Inc.Passive13G/A———